News for Healthier Living

Mayo Clinic Research Supports Targeted Therapy to Manage Kidney Complications, Potentially Enabling Continuation of Lifesaving Immunotherapy

Immune checkpoint inhibitors (ICIs) have transformed cancer treatment but can cause kidney-related immune complications in some patients, sometimes requiring therapy to be paused or stopped. A study led by Dr. Sandra Herrmann at Mayo Clinic sheds light on how this inflammation develops and offers early evidence for a targeted approach to better manage--and potentially prevent--these side effects.

April 22, 2026


April 22 2026

April 21 2026

April 20 2026

April 19 2026

April 18 2026

April 17 2026

April 16 2026

April 15 2026

April 14 2026

April 13 2026

April 12 2026

April 11 2026

April 10 2026

April 9 2026